| Fiscal Period | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Period End Date | Mar 26 | Mar 25 | Mar 24 | Mar 23 |
| Total Liabilities Shareholders' Equity | 539.39 | 472.02 | 446.82 | 341.58 |
| Accumulated Depreciation Total | -106.36 | -91.53 | -87.27 | -74.42 |
| Accrued Expenses | 6.85 | 7.01 | 4.99 | 5.71 |
| Long Term Debt | 41.59 | 40.30 | 35.60 | 24.62 |
| Common Stock Total | 53.50 | 48.73 | 48.73 | 48.73 |
| Other Equity Total | 4.81 | 2.61 | 2.09 | 1.96 |
| Other Current Assets Total | 24.65 | 18.45 | 28.95 | 21.80 |
| Prepaid Expenses | 2.90 | 2.40 | 1.83 | 1.75 |
| Total Assets | 539.39 | 472.02 | 446.82 | 341.58 |
| Current Portof LT Debt/ Capital Leases | 21.85 | 22.85 | 18.04 | 13.48 |
| Additional Paid- In Capital | 38.15 | 8.03 | 8.03 | 8.03 |
| Cash | 42.93 | 2.04 | 9.88 | 6.42 |
| Total Equity | 296.15 | 252.24 | 238.75 | 200.35 |
| Long Term Investments | 0.05 | 0.05 | 0.05 | 0.05 |
| Retained Earnings( Accumulated Deficit) | 197.26 | 191.52 | 179.90 | 141.63 |
| Total Common Shares Outstanding | 5.35 | 4.87 | 4.87 | 4.87 |
| Property/ Plant/ Equipment Total- Gross | 321.55 | 293.93 | 267.70 | 195.98 |
| Tangible Book Valueper Share Common Eq | 47.48 | 45.13 | 44.35 | 38.23 |
| Goodwill Net | 0.17 | 0.17 | 0.17 | 0.17 |
| Total Liabilities | 243.23 | 219.79 | 208.08 | 141.23 |
| Total Debt | 126.40 | 117.68 | 111.63 | 62.00 |
| Short Term Investments | 0.49 | 0.31 | 0.32 | - |
| Cashand Short Term Investments | 43.42 | 2.34 | 10.20 | 6.42 |
| Total Receivables Net | 109.15 | 106.92 | 103.49 | 98.87 |
| Notes Payable/ Short Term Debt | 62.13 | 52.46 | 55.04 | 22.88 |
| Deferred Income Tax | 10.42 | 11.05 | 10.10 | 4.80 |
| Accounts Receivable- Trade Net | 109.04 | 106.92 | 103.49 | 98.74 |
| Property/ Plant/ Equipment Total- Net | 215.19 | 202.40 | 180.45 | 121.56 |
| Minority Interest | 0.00 | 0.00 | 0.00 | - |
| Total Current Liabilities | 190.39 | 166.36 | 159.43 | 110.79 |
| Total Inventory | 95.68 | 101.19 | 83.18 | 62.10 |
| ESOP Debt Guarantee | 2.43 | 1.35 | - | - |
| Accounts Payable | 72.93 | 69.51 | 62.38 | 58.24 |
| Other Currentliabilities Total | 26.64 | 14.54 | 18.97 | 10.48 |
| Total Long Term Debt | 42.42 | 42.37 | 38.55 | 25.64 |
| Intangibles Net | 41.95 | 32.17 | 22.49 | 13.92 |
| Other Long Term Assets Total | 3.27 | 2.87 | 2.50 | 2.19 |
| Note Receivable- Long Term | 2.95 | 3.05 | 13.52 | 12.74 |
| period Length | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Current Assets | 275.81 | 231.31 | 227.65 | 190.95 |
| Capital Lease Obligations | 0.83 | 2.07 | 2.95 | 1.02 |
ZIM Laboratories Dividend ZIM Laboratories Bonus ZIM Laboratories News ZIM Laboratories AGM ZIM Laboratories Rights ZIM Laboratories Splits ZIM Laboratories Board Meetings ZIM Laboratories Key Metrics ZIM Laboratories Shareholdings ZIM Laboratories Profit Loss ZIM Laboratories Cashflow ZIM Laboratories Q1 Results ZIM Laboratories Q2 Results ZIM Laboratories Q3 Results ZIM Laboratories Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.